How many drugs treat Hyperhidrosis of axilla?

Drug Landscape tracks 3 marketed treatments for Hyperhidrosis of axilla (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/hyperhidrosis-of-axilla.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-11 · How we verify

Hyperhidrosis of axilla — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hyperhidrosis of axilla (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Hyperhidrosis of axilla, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cuvposa	GLYCOPYRRONIUM BROMIDE	Shionogi	Anticholinergic	Muscarinic acetylcholine receptor M1	1961-01-01
Glycopyrrolate	Glycopyrrolate	Yonsei University		Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3
Sialanar	Sialanar	Proveca Pharma Limited		Muscarinic acetylcholine receptor M1, Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M3

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Proveca Pharma Limited · 1 drug in Hyperhidrosis of axilla
Shionogi · 1 drug in Hyperhidrosis of axilla
Yonsei University · 1 drug in Hyperhidrosis of axilla

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Hyperhidrosis of axilla:

Cite this brief

Drug Landscape (2026). Hyperhidrosis of axilla — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/hyperhidrosis-of-axilla. Accessed 2026-06-11.

Hyperhidrosis of axilla full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing